Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Multicenter Study

Clinical Trial, Phase III

Comparative Study

Review

Publication Year

From

Quick links

Individual year

2021

2020

2019

2017

2015

2014

2009

2007

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Norfloxacin""[mesh_terms]

11 Results

Searching titles within these results

Norfloxacin-induced effect on enhanced biological phosphorus removal from wastewater after long-term exposure.

Qiuxiang Xu, Xuran Liu, Guojing Yang, Dongbo Wang, Yanxin Wu, Yifu Li, Xiaoding Huang, Qizi Fu, Qilin Wang, Yiwen Liu, Xiaoming Li, Qi Yang

Journal of hazardous materials 2021;392():122336

Full Text

Abstract

Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability.

E Kłosińska-Szmurło, F A Pluciński, A P Mazurek, J Biernacka, K Betlejewska-Kielak, M Grudzień

Journal of biological physics 2015;40(4):335-45

Free Full Text

Abstract

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.

Javier Fernández, Miquel Navasa, Ramón Planas, Silvia Montoliu, David Monfort, German Soriano, Carmen Vila, Alberto Pardo, Enrique Quintero, Victor Vargas, Jose Such, Pere Ginès, Vicente Arroyo

Gastroenterology 2007;133(3):818-24

Full Text

Abstract

Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia.

Arif Al-Hamad, Mathew Upton, James Burnie

The Journal of antimicrobial chemotherapy 2009;64(4):731-4

Full Text

Abstract

Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.

M Assem, M Elsabaawy, M Abdelrashed, S Elemam, S Khodeer, W Hamed, A Abdelaziz, G El-Azab

Hepatology international 2017;10(2):377-85

Full Text

Abstract

Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis.

Richard Moreau, Laure Elkrief, Christophe Bureau, Jean-Marc Perarnau, Thierry Thévenot, Faouzi Saliba, Alexandre Louvet, Pierre Nahon, Adrien Lannes, Rodolphe Anty, Sophie Hillaire, Blandine Pasquet, Violaine Ozenne, Marika Rudler, Isabelle Ollivier-Hourmand, Marie Angèle Robic, Louis d'Alteroche, Vincent Di Martino, Marie-Pierre Ripault, Arnaud Pauwels, Jean-Didier Grangé, Nicolas Carbonell, Jean-Pierre Bronowicki, Audrey Payancé, Pierre-Emmanuel Rautou, Dominique Valla, Nathalie Gault, Didier Lebrec

Gastroenterology 2019;155(6):1816-1827.e9

Free Full Text

Abstract

UPLC-based assay to assess the hydrophobicity of Antibody-Drug Conjugate (ADC) payloads.

David E Thurston, Khondaker Miraz Rahman, David J Barlow, Paul J M Jackson, Ilona Pysz

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2020;1146():122075

Full Text

Abstract

Novel organic salts based on fluoroquinolone drugs: synthesis, bioavailability and toxicological profiles.

Catarina Florindo, Alexandra Costa, Carla Matos, Sara L Nunes, Ana N Matias, Catarina M M Duarte, Luís Paulo N Rebelo, Luís C Branco, Isabel M Marrucho

International journal of pharmaceutics 2015;469(1):179-89

Full Text

Abstract

Structural Insights into the Fluoroquinolone Resistance Mechanism of Shigella flexneri DNA Gyrase and Topoisomerase IV.

Jayashree Ramana

Microbial drug resistance (Larchmont, N.Y.) 2017;22(5):404-11

Full Text

Abstract

Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.

Jigar Bhagatwala, Satish S C Rao

Clinical and translational gastroenterology 2020;10(10):e00078

Free Full Text

Abstract

Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.

Nitin Gupta, Ashish Kumar, Praveen Sharma, Vishal Garg, Barjesh C Sharma, Shiv K Sarin

Liver international : official journal of the International Association for the Study of the Liver 2014;33(8):1148-57

Full Text

Abstract

Results: 1 – 11 / 11

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Norfloxacin""[mesh_terms]

Norfloxacin-induced effect on enhanced biological phosphorus removal from wastewater after long-term exposure.

Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability.

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.

Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia.

Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.

Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis.

UPLC-based assay to assess the hydrophobicity of Antibody-Drug Conjugate (ADC) payloads.

Novel organic salts based on fluoroquinolone drugs: synthesis, bioavailability and toxicological profiles.

Structural Insights into the Fluoroquinolone Resistance Mechanism of Shigella flexneri DNA Gyrase and Topoisomerase IV.

Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.

Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.

Results for
""Norfloxacin""[mesh_terms]